Filters
Filtered by tag: consortium × Clear
Insilico Medicine Convenes an Open Consortium For Benchmark Quality in AI-Driven Drug Discovery
Matched: AI, Artificial Intelligence
Insilico Medicine launched the Open Drug Discovery and Development Consortium (O3DC), a free community-curated initiative aimed at improving transparency in AI-driven drug discovery benchmarks. Its Benchmark Index catalogs hundreds of benchmarks across 10 categories, documenting known biases and limitations often omitted from standard benchmark descriptions. Insilico applies the same scrutiny to its own tools, openly noting their flaws. Researchers can contribute, challenge entries, or add benchmarks at o3dc.org.